External broker reports(aggregated public sources), Taylor Collison

Taylor Collison

Taylor Collison is a leading financial services firm, providing advice & wealth creation strategies to private & institutional investors and corporate clients throughout Australia. Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

External broker reports(aggregated public sources)

Equity Bottom-Up

<ul><li>GSS reported $2.0m sales in Q323, falling below our expectations as Covid and other respiratory testing tailed off more quickly than we had anticipated.</li><li>On a positive note, sales in April were over $1.0m, suggesting Q423 sales will likely rebound to ~$4m as the winter flu season builds in Australia.</li><li>We cut our sales forecasts by 18% and 8% in FY23 and FY24, respectively.</li></ul><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

GSS reported $2.0m sales in Q323, falling below our expectations as Covid and other respiratory testing tailed off more quickly than we had anticipated.On a positive note, sales in April were over $1.0m, suggesting Q423 sales will likely rebound to ~$4m as the winter flu season builds in Australia.We cut our sales forecasts by 18% and 8% in FY23 and FY24, respectively.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Genetic Signatures (GSS) - Sales Disappoint but Key Catalyst Approaching